Atacicept
- Generic Name
- Atacicept
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 845264-92-8
- Unique Ingredient Identifier
- K3D9A0ICQ3
- Background
Atacicept is a recombinant fusion protein combined with the extracellular ligand binding portion of TACI.
- Indication
Investigated for use/treatment in autoimmune diseases, systemic lupus erythematosus, rheumatoid arthritis, multiple myeloma, lymphoma (non-hodgkin's), and leukemia (lymphoid).
- Associated Conditions
- -
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath